Haoyun An

1.8k total citations
62 papers, 1.5k citations indexed

About

Haoyun An is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Haoyun An has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 33 papers in Organic Chemistry and 10 papers in Infectious Diseases. Recurrent topics in Haoyun An's work include Chemical Synthesis and Analysis (19 papers), Biochemical and Molecular Research (10 papers) and HIV/AIDS drug development and treatment (10 papers). Haoyun An is often cited by papers focused on Chemical Synthesis and Analysis (19 papers), Biochemical and Molecular Research (10 papers) and HIV/AIDS drug development and treatment (10 papers). Haoyun An collaborates with scholars based in United States, China and Belgium. Haoyun An's co-authors include P. Dan Cook, Jerald S. Bradshaw, Reed M. Izatt, Sidney M. Hecht, Zhengming Yan, Richard H. Griffey, Tingmin Wang, Ralph T. Scannell, Krzysztof E. Krakowiak and Zhi Hong and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

In The Last Decade

Haoyun An

62 papers receiving 1.4k citations

Peers

Haoyun An
Leslie W. Deady Australia
Haoyun An
Citations per year, relative to Haoyun An Haoyun An (= 1×) peers Leslie W. Deady

Countries citing papers authored by Haoyun An

Since Specialization
Citations

This map shows the geographic impact of Haoyun An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoyun An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoyun An more than expected).

Fields of papers citing papers by Haoyun An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoyun An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoyun An. The network helps show where Haoyun An may publish in the future.

Co-authorship network of co-authors of Haoyun An

This figure shows the co-authorship network connecting the top 25 collaborators of Haoyun An. A scholar is included among the top collaborators of Haoyun An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoyun An. Haoyun An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Hang, Haoyun An, & Jing‐Chao Tao. (2019). Investigation of 8-Aza-7-Deaza Purine Nucleoside Derivatives. Molecules. 24(5). 983–983. 7 indexed citations
2.
Han, Liqiang, Xia Yuan, Xingyu Wu, et al.. (2016). Urea-containing peptide boronic acids as potent proteasome inhibitors. European Journal of Medicinal Chemistry. 125. 925–939. 26 indexed citations
3.
Ren, Hang, et al.. (2015). Versatile synthesis and biological evaluation of novel 3’-fluorinated purine nucleosides. Beilstein Journal of Organic Chemistry. 11. 2509–2520. 14 indexed citations
4.
Zheng, Liyun, Qiang Wang, Xiaorui Yang, et al.. (2012). Antiviral Activity of Fnc, 2′-Deoxy-2′-β-Fluoro-4′-Azidocytidine, against Human and Duck HBV Replication. Antiviral Therapy. 17(4). 679–687. 30 indexed citations
5.
Guo, Xiaohe, Yujiang Li, Qiang Wang, et al.. (2011). Synthesis and anti-HIV-1 activity of 4-substituted-7-(2′-deoxy-2′-fluoro-4′-azido-β-d-ribofuranosyl)pyrrolo[2,3-d]pyrimidine analogues. Bioorganic & Medicinal Chemistry Letters. 21(22). 6770–6772. 23 indexed citations
6.
Xu, Wanhong, Brian Xi, Jieying Wu, et al.. (2009). Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of β-tubulin at Cys 12 and suppression of microtubule dynamics. Molecular Cancer Therapeutics. 8(12). 3318–3330. 22 indexed citations
7.
Pan, Hao, Hui Zhou, Su Zeng, et al.. (2009). Identification and simultaneous determination of p-FHA and p-FBA, two metabolites of anti-tumor agent—Fluorapacin in rat urine. Journal of Chromatography B. 877(14-15). 1553–1560. 6 indexed citations
8.
Gu, Liqiang, Liping Li, Zhongjian Chen, et al.. (2008). Determination of anti-tumor agent bis(p-fluorobenzyl)trisulfide and its degraded compound in rat blood using reversed phase high-performance liquid chromatography. Journal of Chromatography B. 868(1-2). 77–82. 4 indexed citations
9.
An, Haoyun, Xiu-Rong Hu, Linshen Chen, et al.. (2008). Crystal Structure Determination of New Antimitotic Agent Bis(p-fluorobenzyl)trisulfide. AAPS PharmSciTech. 9(2). 551–556. 3 indexed citations
10.
He, Yuyu, et al.. (2007). Quantitative determination of anti-tumor agent bis(4-fluorobenzyl)trisulfide, fluorapacin and its pharmaceutical preparation by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 46(1). 206–210. 5 indexed citations
11.
Ramasamy, Kanda S., Jean‐Luc Girardet, Esmir Gunić, et al.. (2006). Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents. Bioorganic Chemistry. 35(1). 25–34. 41 indexed citations
12.
An, Haoyun, Jenny Zhu, Xiaobo Wang, & Xiao Xu. (2006). Synthesis and anti-tumor evaluation of new trisulfide derivatives. Bioorganic & Medicinal Chemistry Letters. 16(18). 4826–4829. 29 indexed citations
13.
An, Haoyun, et al.. (2006). Solid-Phase Synthesis of 5′-Deoxy-5′-Amino-Clitocine Analogues. Nucleosides Nucleotides & Nucleic Acids. 25(1). 61–72. 2 indexed citations
14.
Ding, Yili, Jean‐Luc Girardet, Zhi Hong, et al.. (2004). Synthesis of 9-(2-β-C-methyl-β-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication. Bioorganic & Medicinal Chemistry Letters. 15(3). 709–713. 24 indexed citations
15.
Smith, Kenneth L., Vicky C. H. Lai, Brett J. Prigaro, et al.. (2004). Synthesis of new 2′-β-C-methyl related triciribine analogues as anti-HCV agents. Bioorganic & Medicinal Chemistry Letters. 14(13). 3517–3520. 10 indexed citations
16.
Ding, Yili, Haoyun An, Zhi Hong, & Jean‐Luc Girardet. (2004). Synthesis of 2′-β-C-methyl toyocamycin and sangivamycin analogues as potential HCV inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(3). 725–727. 16 indexed citations
17.
Egli, Martin, Valentina Tereshko, Marianna Teplova, et al.. (1998). X-ray crystallographic analysis of the hydration of A- and B-form DNA at atomic resolution. Biopolymers. 48(4). 234–234. 112 indexed citations
18.
Griffey, Richard H., et al.. (1998). Rapid deconvolution of combinatorial libraries using HPLC fractionation. Tetrahedron. 54(16). 4067–4076. 18 indexed citations
19.
An, Haoyun, Jerald S. Bradshaw, Krzysztof E. Krakowiak, et al.. (1993). Novel benzene-bridged macrobi- and macrotricyclic polyethers. The Journal of Organic Chemistry. 58(27). 7694–7699. 24 indexed citations
20.
Bradshaw, Jerald S., Krzysztof E. Krakowiak, Haoyun An, & Reed M. Izatt. (1990). Preparation of macrocyclic di‐ and tetraamides containing unsubstituted macroring nitrogen atoms, tertiary amine sidearms and/or piperazine subcyclic units. Journal of Heterocyclic Chemistry. 27(7). 2113–2116. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026